Search Results - "Velazquez, Maria Natalia Rojas"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels by Rojas Velazquez, Maria Natalia, Noebauer, Mathias, Pandey, Amit V

    “…Cytochrome P450 oxidoreductase (POR) is the redox partner of steroid and drug-metabolising cytochromes P450 located in the endoplasmic reticulum. Mutations in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase by Parween, Shaheena, Rojas Velazquez, Maria Natalia, Udhane, Sameer S., Kagawa, Norio, Pandey, Amit V.

    Published in Frontiers in pharmacology (15-10-2019)
    “…Cytochromes P450 located in the endoplasmic reticulum require NADPH cytochrome P450 oxidoreductase (POR) for their catalytic activities. Mutations in POR cause…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Exploring Novel Variants of the Cytochrome P450 Reductase Gene ( POR ) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays by Rojas Velazquez, Maria Natalia, Therkelsen, Søren, Pandey, Amit V

    Published in Biomolecules (Basel, Switzerland) (30-11-2023)
    “…Cytochrome P450 oxidoreductase (POR) is an essential redox partner for steroid and drug-metabolizing cytochromes P450 located in the endoplasmic reticulum…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Loss of protein stability and function caused by a single point mutation (P228L) in the Cytochrome P450 Oxidoreductase by Rojas Velazquez, Maria Natalia, Noebauer, Mathias, Pandey, Amit V.

    Published in The FASEB journal (01-05-2022)
    “…Cytochrome P450 oxidoreductase (POR) is the obligatory redox partner of steroid and drug metabolizing cytochrome P450s located in the endoplasmic reticulum…”
    Get full text
    Journal Article
  12. 12

    PMON52 Use of PDE5 Inhibitors as Potential Treatment for Isolated Growth Hormone Deficiency Caused by Alternate Splicing of GH1 Gene by Pandey, Amit V, Velazquez, Maria Natalia Rojas

    Published in Journal of the Endocrine Society (01-11-2022)
    “…Mutations in the GH1 gene cause isolated growth hormone deficiency (IGHD) by affecting production, secretion, and stability of growth hormone as well as its…”
    Get full text
    Journal Article
  13. 13

    Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase by Velazquez, Maria Natalia Rojas, Parween, Shaheena, Udhane, Sameer S., Pandey, Amit V.

    “…A broad spectrum of human diseases are caused by mutations in the NADPH cytochrome P450 oxidoreductase (POR). Cytochrome P450 proteins perform several…”
    Get full text
    Journal Article
  14. 14